Back
ESC Premium Access

Perceived or calculated bleeding risk in patients undergoing percutaneous coronary intervention: inside the post-pci prospective registry

Session: Safety issues with anti-platelets drugs
Topic: Antiplatelet Drugs
Speaker: Doctor M. Ferlini (Pavia, IT)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Marco Ferlini

Foundation IRCCS Policlinic San Matteo - University of Pavia, Pavia (Italy)
0 follower

3 more presentations in this session

Are perceived or calculated bleeding risk related to dapt choice in patients undergoing percutaneous coronary intervention?

Speaker: Doctor M. Ferlini (Pavia, IT)

Access
Abstract
Like
Thumbnail

Platelet inhibition on brand and generic clopidogrel chronic therapy

Speaker: Doctor A. Soliman (Dammam, SA)

Access
Abstract
Slides
Video
Like
Thumbnail

Adverse event profiles after brand or generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS)

Speaker: Associate Professor V. Serebruany (Baltimore, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Safety issues with anti-platelets drugs

Speakers: Doctor M. Ferlini, Doctor M. Ferlini, Doctor A. Soliman, Associate Professor V. Serebruany
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources